about
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a ...
Read More
1.15
0.01
(0.88%)
77,433
XNAS Volume
XNAS 10 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Boundless Bio Inc is on 11 Mar 2026 for the purpose of Leerink Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..